''REOR'' medications was founded in 1990 by the president of the Academy of Sciences of the Azerbaijan Republic to develop medications based on amino acid derivatives.
Advertisement: Information about a new generation of ''REOR'' BAS ''REOR'' medications appeared in the result of many years of scientific investigations. The medications were patented by the Research Institute of Methodology and Safety of curative means that existed at that time under the Ministry of Medical and Biological industry of the USSR in 1984 and they received appropriate registrations numbers.''REOR'' medications are new curative means, which are obtained by organic synthesis on the basis of using biological substances and natural raw materials. This medication has no cancerogenic and toxic effects, does not cause any change in internal organs and produces no tumors. No immature forms of cell elements erythrocyte and leukocyte series were noticed. These medications are easily utilized by the body, do not possess cumulative effect and handy in use.Among the scientific centers which have provided written conclusions are: Department of Pathological and Normal Physiology, Microbiology, Gystology, Embryology and Cytology, Dental Surgery, and the Central Research Laboratory of the Medical University; A. Karayev Institute Physiology; Institute of Epidemiology, Hygiene and Professional Diseases; and also institute of Gynaecology and Obstetrics of the Ministry of the Health of Azerbaijan. The abovementioned patents were received due to synthesis of new biologically active structures against following disease:
1. Staphylococcus, e. coil, bluegreen pusbacillusli, diphtheria and gas gangrene (in vitro, in vivo);
2. Plague, cholera, tularemia, brucellosis, intestinal iersinioza, pseudotuberulosis (in vitro);
3. Amaeba Disenteria ; Eimeria tenella (in vitro, in vivo);
4. Neurotrophic ulcers in patents after backbone traum
5. Use of bioactive substances for rapid reparative repair of bone
6. Treatment of Demodekozis eye disease by EGAS medication
A d d i t o n a l :
1. Can prognoses and create a new antiviral BAS
P r o g n o s i s:
a) To destroy the sequence of configuration of proteinbase surrounding of virus.
 b) To block the synthesis of viral DWA  C o n f i r m a t i o n:
New BAS with grippe A activity was developed and patent got
P r o g n o s i s:
To develop a new BAS with antidiabetic activity to reduce the level of sugar in blood when after drugs is impossible to reduce the level of sugar
C o n f i r m a t i o n:
Developed BAS was confirmed by infrared spectrometry (SPECORD, GERMANY).
 In view of absence of other virus cultural Azerbaijan Republic except of virus cultural of grip A ''REOR'' firm's administration is ready to cooperate with various scientificmedical research centers of the world engaged in probation of a new BAS against various virus cultures including (adeno-, arbo-, retro - AIDS ) .
FIELD OF SCIENTIFIC INTEREST:
1. Treatment of untreatable by enhancing of immune system
P r o g n o s i s:
a) Every disease has its own sign in blood.
b) To bring changed parameters in blood to normal.
C o n f i r m a t i o n :
I. PHOTOS OF HYSTOLOGICAL SLIDES OF CANCEROUS ONCOLOGY PATIENT.
Hystological checking of blood smear (serial photos) October 1996
| 20 x 100 |  | | 10 x 100 |  | | Hystological checking of blood smear during the treatment (serial photos) November 1996 | | 20 x 100 |  | | 10 x 100 |  | | January 1997 | | 20 x 100 |  | | 10 x 100 |  | | May 1997 | | 20 x 100 |  | | 10 x 100 |  | | May 2000 | | 20 x 100 |  | | 10 x 100 |  | |
| Diagnose: Benign swelling formation - Adenoma of Hypophysis
Confirmed by Gulhane Army Medical Academy in Turkey Prepared on the basis of official documents.
Patient: Before the treatment: 1998 The size of Adenoma of hypophysis: 5.0*6.0*6.0 sm. Examination of ocular organs: Right: Total = 1060(dB)
Left: Total = 889(dB)
Prolactin > 221 ngr/ml.
Patient: During the treatment: Was surgically operated. After the operation size of hypophysisal adenoma reached to
3.1*4.5*5.5 sm. Prolactin > 221 ngr/ml.
In 1999 the size of hypophysisal adenoma reached to 3.2*4.1*4.3 sm. Treatment continued with hormone and other medicines. The size of hypophysisal adenoma was 2.6*4.1*4.3 sm.
Patient had radiotherapy in a dose of 55-Gr.
1Gr = 100 rad Prolactin > 221 ngr/ml.
In 2000 after the radiotherapy size of hypophysisal adenoma increased in compare with previous size and reached to 2.8*4.6*.5.2 sm. Treatment followed continuously with hormone and other medicines. After certain time size of hypophysisal adenoma reached to 3.0*3.6*4.9 sm. Prolactin > 221 ngr/ml. By 2001 left size of hypophysisal adenoma has not changed and was: 3.0*3.6*4.9 sm. Prolactin > 221 ngr/ml. Examination of ocular organs: Right: Total = 1171(dB)
Left: Total = 1038 (dB)
Patient was not able to continue course of treatment in Turkey.
Reason: - After taking hormonal medicines, patient was observed by high fatness and dyspnea, amount of prolactin and size of adenoma hypophysis remained stable. In 2001 In Azerbaijan the patient has received untraditional medicine treatment according to blood analyses in order to increase immunity. Eight months late, the patient has been referred to Turkey-Gulhane Army Medical
Academy to have re-examination.
The result of medical survey: 1. Examination of ocular organs: Right: Total = 1372(dB)
Left: Total = 1076 (dB) Prolactin = 219 ngr/ml. Conclusion: during the examination hypophysisal adenoma 13*12*34 mm. |
